Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) price on current trading day, fall -1.39% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $16.35.
A look at the stock’s price movement, the level at last check in today’s session was $16.58, moving within a range at $16.32 and $16.59. The beta value (5-Year monthly) was 0.598. Turning to its 52-week performance, $22.80 and $12.47 were the 52-week high and 52-week low respectively. Overall, TEVA moved -4.33% over the past month.
Teva- Pharmaceutical Industries Ltd. ADR’s market cap currently stands at around $18.75 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-07.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TEVA is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 6 recommend TEVA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TEVA’s current price about -0.99% and -3.48% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.05, while 7-day volatility ratio is 2.14% and 2.28% in the 30-day chart. Further, Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has a beta value of 0.63. Analysts have given the company’s stock an average 52-week price target of $22, forecast between a low of $10 and high of $28. Looking at the price targets, the low is 38.84% off recent price level in today’s trading while to achieve the yearly target high, it has to move -71.25%. Nonetheless, investors will most likely welcome a -34.56% jump to $22 which is the analysts’ median price.
If we refocus on Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA), historical trading data shows that trading volumes averaged 10.54 over the past 10 days and 11.60 million over the past 3 months. The company’s latest data on shares outstanding shows there are 1.15 billion shares.
The 0.01% of Teva- Pharmaceutical Industries Ltd. ADR’s shares are in the hands of company insiders while institutional holders own 62.97% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 39.87 million on 2025-06-30, giving us a short ratio of 3.59. The data shows that as of 2025-06-30 short interest in Teva- Pharmaceutical Industries Ltd. ADR (TEVA) stood at 349.0 of shares outstanding, with shares short rising to 35.67 million registered in 2025-05-30. Current price change has pushed the stock -3.71% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TEVA stock continues to rise going into the next quarter.
